On 8/2/24, Tandem Diabetes Care Inc (NASDAQ: TNDM) stock enjoyed a major increase of 18.3%, closing at $41.67. Moreover, trading volume in this advance was exceptionally high at 276% of normal. The stock has risen 2.5% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
TNDM is expected to continue to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.
Tandem Diabetes Care has a current Value Trend Rating of C (Low Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Tandem Diabetes Care has a very low Appreciation Score of 5 but a very high Power Rating of 90, and the Low Neutral Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment